<DOC>
	<DOCNO>NCT01539564</DOCNO>
	<brief_summary>The objective study evaluate safety effectiveness Arestin ( minocycline HCl ) 1 mg Microspheres treatment subject peri-implantitis , use combination mechanical debridement . The hypothesis study Arestin combination mechanical debridement effective treatment peri-implantitis compare mechanical debridement alone . The primary efficacy measure reduction probe depth Day 180 measure qualify implant site .</brief_summary>
	<brief_title>Arestin - Use Subjects With Peri-Implantitis</brief_title>
	<detailed_description />
	<mesh_term>Peri-Implantitis</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>A minimum one osseointegrated implant diagnosis periimplantitis Absence significant oral soft tissue pathology At least one periimplant site average 2 probe depth reading 5mm 7mm ( inclusive ) use light force bleed probe within 30 second probe Confirmed evidence pathologic bone loss At least 1mm keratinize gingiva present around implant Pregnancy Allergy tetracyclineclass drug ( ) Systemic medical condition ( ) require antibiotic prophylaxis prior invasive dental procedure Presence active systemic infectious disease hepatitis , HIV , history tuberculosis Diagnosis clinically significant unstable organic disease , compromise heal potential Signs untreated advanced periodontal disease and/or poor oral hygiene Subjects probe depth great 8mm time enrollment Subjects present mobility dental implant Subjects qualify implant occlusal trauma overload ( determined investigator )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>